Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.59 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.59 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | TYR | P14679 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | P4HB | P07237 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10710403 | 1.00 | MAPT (0.59) | MAPTMEN1HTTKMT2AFTO | |
| SCHEMBL1029869 | 1.00 | MAPT (0.59) | MAPTMEN1HTTKMT2AFTO | |
| SCHEMBL20777527 | 1.00 | MAPT (0.59) | MAPTMEN1HTTKMT2AFTO | |
| SCHEMBL3695146 | 1.00 | MAPT (0.59) | MAPTMEN1HTTKMT2AFTO | |
| SCHEMBL29661300 | 1.00 | MAPT (0.59) | MAPTMEN1HTTKMT2AFTO | |
| SCHEMBL597089 | 1.00 | MAPT (0.59) | MAPTMEN1HTTKMT2AFTO | |
| SCHEMBL20777529 | 0.95 | CYP3A4 (0.55) | MAPTMEN1HTTKMT2AFTO | |
| SCHEMBL402758 | 0.95 | CYP3A4 (0.55) | MAPTMEN1HTTKMT2AFTO | |
| SCHEMBL1032639 | 0.95 | CYP3A4 (0.55) | MAPTMEN1HTTKMT2AFTO | |
| SCHEMBL10606489 | 0.95 | CYP3A4 (0.55) | MAPTMEN1HTTKMT2AFTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117165655-A | Rapid pathogen-specific enzymatic drug sensitivity analysis method | 浙江大学 | 2023-12-05 | — | — | CN | claimed |
| US-9701968-B2 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2017-07-11 | — | — | US | claimed |
| US-20160312263-A1 | BIOLOGICAL INDICATOR | AMERICAN STERILIZER CO (US) | 2016-10-27 | — | — | US | claimed |
| US-20160102335-A1 | BIOLOGICAL INDICATOR | AMERICAN STERILIZER COMPANY | 2016-04-14 | — | — | US | claimed |
| US-8895239-B2 | Genetically engineered biological indicator | AMERICAN STERILIZER COMPANY (US) | 2014-11-25 | — | — | US | claimed |
| EP-2084293-B1 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | AMERICAN STERILIZER CO (US) | 2014-08-13 | — | — | EP | claimed |
| US-8507248-B2 | Genetically engineered biological indicator | AMERICAN STERILIZER COMPANY (US) | 2013-08-13 | — | — | US | claimed |
| US-20130130292-A1 | Method for detecting replication or colonization of a biological therapeutic | GENELUX CORPORATION | 2013-05-23 | — | — | US | claimed |
| US-20100267044-A1 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | FRANCISKOVICH PHILLIP P | 2010-10-21 | — | — | US | claimed |
| EP-2084293-A2 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | American Sterilizer Company (US) | 2009-08-05 | — | — | EP | claimed |
| WO-2008079469-A2 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | AMERICAN STERILIZER COMPANY (US) | 2008-07-03 | — | — | WO | claimed |
| US-20080070231-A1 | Reporter genes taken up by microorganism, and repressor gene inhibits expression | AMERICAN STERILIZER COMPANY | 2008-03-20 | — | — | US | claimed |
| US-5604091-A | ENZYME DONOR POLYPEPTIDE HAVING SPECIFIED AMINO ACID SEQUENCE; QUALITATIVE AND QUANTITATIVE ANALYSIS | MICROGENICS CORPORATION (US) | 1997-02-18 | — | — | US | claimed |
| EP-0199801-A4 | METHODS FOR PROTEIN BINDING ENZYME COMPLEMENTATION ASSAYS. | MICROGENICS CORP (US) | 1988-12-15 | — | — | EP | claimed |
| EP-0199801-A1 | METHODS FOR PROTEIN BINDING ENZYME COMPLEMENTATION ASSAYS. | MICROGENICS CORP (US) | 1986-11-05 | — | — | EP | claimed |
| WO-1986002666-A1 | METHODS FOR PROTEIN BINDING ENZYME COMPLEMENTATION ASSAYS | MICROGENICS CORPORATION (US) | 1986-05-09 | — | — | WO | claimed |
| US-12043653-B2 | Efficient delivery of therapeutic molecules to cells of the inner ear | MASSACHUSETTS EYE AND EAR INFIRMARY (US) | 2024-07-23 | — | — | US | disclosed |
| CN-118348260-A | Parkinson disease diagnosis marker combination and application thereof | 香港中文大学（深圳） | 2024-07-16 | — | — | CN | disclosed |
| EP-0199801-A1 | METHODS FOR PROTEIN BINDING ENZYME COMPLEMENTATION ASSAYS. | MICROGENICS CORP (US) | 1986-11-05 | — | — | EP | disclosed |
| WO-1986002666-A1 | METHODS FOR PROTEIN BINDING ENZYME COMPLEMENTATION ASSAYS | MICROGENICS CORPORATION (US) | 1986-05-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043653-B2 | Efficient delivery of therapeutic molecules to cells of the inner ear | HES1, NOTCH1, NOTCH2 | MAPT 3320/4885MEN1 254/4885HTT 2538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.